Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

Statement re. Harbinger Capital Partners

9 Nov 2009 14:46

RNS Number : 2084C
FRM Credit Alpha Limited
09 November 2009
 



FRM Credit Alpha Limited (the "Company")

9 November 2009

Since the final Net Asset Value for 30 September 2009 was calculated and determined by the Company's administrator, further information has been made available to the Company relating to the value of its investment in Harbinger Capital Partners Special Situations Offshore Fund ("HCPSS") as at 30 September 2009.

In accordance with the Company's Net Asset Value calculation policy, the 30 September 2009 Net Asset Value was calculated using an estimated net asset value for HCPSSHCPSS has now released its final 30 September 2009 net asset value, which is significantly higher than its estimate net asset value. The reason for this revision is due to Harbinger now expecting a greater recovery of its assets from the Lehman Brothers International (Europe) administration.

The revision of the net asset value for HCPSS will cause an increase in the Company's Net Asset Value per share of 1.06%. This increase will be reflected in the Company's published 31 October 2009 Net Asset Value.

Contacts: 

FRM 

Mark Shaw 020 7968 6141

Greg Taylor 020 7968 6206

Winterflood Securities

Jane Lewis 020 3100 0295

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUKSSRKARARAA
Date   Source Headline
1st Jun 20217:00 amRNSBlock Admission Return and Total Voting Rights
13th May 20217:00 amRNSDirector Dealing, Option Exercise & TVR
30th Apr 20217:00 amRNSTotal Voting Rights
8th Apr 202111:06 amRNSSecond Price Monitoring Extn
8th Apr 202111:00 amRNSPrice Monitoring Extension
7th Apr 20217:00 amRNSFY21 Unaudited Total Income - Strong end to FY21
1st Apr 20217:00 amRNSTotal Voting Rights
5th Mar 20219:16 amRNSDirectors’ Dealings
3rd Mar 20214:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:35 pmRNSPrice Monitoring Extension
3rd Mar 20211:55 pmRNSFY21 Trading Update
1st Mar 20217:00 amRNSTotal Voting Rights
23rd Feb 20217:00 amRNSAppointment of Broker
1st Feb 20217:00 amRNSTotal Voting Rights
4th Jan 20217:00 amRNSTotal Voting Rights
4th Dec 20207:00 amRNSDirector/PDMR Shareholding
1st Dec 20207:00 amRNSBlock Admission Return and Total Voting Rights
18th Nov 202010:54 amRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSBoard Changes
18th Nov 20207:00 amRNSInterim Results and Interim Dividend
30th Oct 20207:00 amRNSTotal Voting Rights
1st Oct 20207:00 amRNSTotal Voting Rights
21st Sep 20202:12 pmRNSResult of AGM
21st Sep 20207:00 amRNSAGM Trading Statement
3rd Sep 20209:12 amRNSOption Exercise - Director/PDMR Shareholding
1st Sep 202011:40 amRNSTotal Voting Rights- Replacement
1st Sep 20207:00 amRNSTotal Voting Rights
17th Aug 20207:00 amRNSAdditional Block Admission of Shares
13th Aug 202012:30 pmRNSOption Grant
31st Jul 202010:18 amRNSAnnual Report and Annual General Meeting Notice
31st Jul 20207:00 amRNSTotal Voting Rights
7th Jul 20207:00 amRNSPreliminary results - year ended 31 March 2020
1st Jul 20207:00 amRNSTotal Voting Rights
16th Jun 20208:56 amRNSChange of Registered Office
1st Jun 20207:00 amRNSBlock Admission Return and Total Voting Rights
26th May 202010:20 amRNSDirector/PDMR Shareholding
26th May 20207:00 amRNSProperty Financing
20th May 20207:00 amRNSDirectorate Changes
6th May 20209:54 amRNSDirector’s Dealing and Concert Party Update
1st May 20207:00 amRNSTotal Voting Rights
2nd Apr 20207:00 amRNSOption Surrenders and Grants
1st Apr 20203:11 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSTrading Update
12th Mar 20201:44 pmRNSHolding(s) in Company
4th Mar 20207:00 amRNSTotal Voting Rights
27th Feb 20207:00 amRNSTrading Update
14th Feb 20207:00 amRNSNew Director Appointment
4th Feb 20207:00 amRNSTotal Voting Rights
23rd Jan 20203:32 pmRNSDirector/PDMR Shareholding
17th Jan 20202:52 pmRNSSigning of new lease to consolidate premises

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.